Mac Pherson titanium tying forceps are ergonomic, very thin, angled with tying platforms. Round ergonomic design for great balance and feel. Fine platforms excellent for tying 10-0 suture.
Helveston tying forceps, standard with smooth jaws. For 4-0 to 6-0 sutures.
Tennant stainless steel tying forceps is extra delicate, straight with smooth jaws, 6 mm long platform, round handle with guide pin. For 9-0 to 11-0 sutures.
Sinskey tying forcep is very delicate with smooth jaws, curved. For 8-0 to 11-0 sutures.
Medicine Products:(Date:8/20/2008)...covery -- that calorie-burning brown fat can be pr...in mice -- raises the prospect of new ways to figh...-Farber Cancer Institute. , Reporting in the Aug...s demonstrated that brown fat, which is known as t...s calories and releases energy, unlike "bad" white...
(Date:8/20/2008).../PRNewswire-USNewswire/ -- Yesterday evening,Cong...ron Hospital after,suffering an aneurysm while dri...esent time Rep. Tubbs Jones, condition has stabili... Tuesday,s condition followed a full day of activ...lectoral reform, scheduled for September 4, 2008,a...
(Date:8/20/2008)...op entertainers helps introduce new light beer, ...LAS, Aug. 20 /PRNewswire/ -- Multi-platinum singer...rinker?, Everyone knows about Jessica Simpson,s d...rican beauty and world-renowned entertainer has a,...oices. But she also makes,those smart choices with...
(Date:8/20/2008)... As the costs of healthcare and gas rise, older A...emselves worrying about how they can afford their ...D.C. (PRWEB) August 20, 2008 -- As the costs of he...d income and resources also find themselves worryi... ,"I have Medicare but I can,t afford prescri...
Breaking Medicine News(10 mins):Health News:Making 'good' fat from muscle and vice versa 2Health News:Making 'good' fat from muscle and vice versa 3Health News:Jessica Simpson Lends Healthy Image for Drink Smart Campaign 2Health News:Jessica Simpson Lends Healthy Image for Drink Smart Campaign 3Health News:Meals or Meds? BenefitsCheckUp Helps Older People Struggling with Food Costs 2...lant Program, beset with administrative problems, ...t, The UCSD communicated its decision to relieve /...and kidney transplants, of his administrative resp... continue as a full-time surgeon and member of the...
...g to the Oxford University in England have reveale...ere to manage their own treatment and taught to sc...600 deaths could be avoided. Those patients who ch...n, according to the thickness of their blood run t...
...osquito-borne disease, chikungunya has affected ab...of Reunion. // This disease has no cure. Though ...n a stooped posture. The prevalence of the disea...s 45 000 new cases since mid-December. Philippe R...
...mmunologist at the U.S. Centers for Disease Contro... influenza virus this year have developed // resis...used for the treatment for flu infection. Drugs b...nd rimantadine are ineffectual for now and for the...
Other Medicine News:Health News:Resistant Influenza strains creates panic in US 2(Date:8/18/2008)... 18 /PRNewswire-USNewswire/ -- Boston University a...he Center for Human Genetics, Inc.,("CHG") and Dir...niversity,announced that CHG will no longer offer...thena Diagnostics, Inc., These patented tests inc...ted to A1555G or Connexin 26 mutations, developmen...
(Date:8/18/2008)... - Clinical trial currently in Phase I -, PRINCE...obira,Therapeutics Inc., a clinical stage biotechn...t discovery against life-threatening and life-alte...ance of Patent No. 7,371,772,B2 by the U.S. Patent..., a,CCR5 antagonist currently in Phase I developme...
(Date:8/14/2008)... Complimentary Continuing Education Activity, VOO...us (CMV) is a,significant cause of morbidity and m...transplantation. The clinical manifestations of CM...nal disease to life-threatening,pneumonia, myelosu... to prevent CMV infection and reduce CMV drug resi...
(Date:8/14/2008)... development to begin in late 2008 or in early 200...tCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) today anno...concept trial of NU172, demonstrating that the dir...ined anticoagulation with a rapid,return toward ba...afety,profile., "NU172 has the potential to addre...
Breaking Medicine Technology:CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Head and Neck Cancer Outcomes a Mixed Bag 14659 1Head and Neck Cancer Outcomes a Mixed Bag 14659 2Eating Disorders Take Center Stage at iaedp 28TM 29 2008 Symposium in Orlando Florida 14657 1Eating Disorders Take Center Stage at iaedp 28TM 29 2008 Symposium in Orlando Florida 14657 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin 9 in Patients with Asthma 1551 1Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin 9 in Patients with Asthma 1551 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin 9 in Patients with Asthma 1551 3Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin 9 in Patients with Asthma 1551 4Killer stairs 3F Taking the elevator could be worse for your body 14654 1Killer stairs 3F Taking the elevator could be worse for your body 14654 2Killer stairs 3F Taking the elevator could be worse for your body 14654 3...n Colorectal Cancer,and in Hormone-Refractory Pros..., June 01, 2007,/PRNewswire-FirstCall/ -- Poniard ...y focused on oncology, today announced,promising r...e 1,dose-escalating trials of picoplatin, a new ge...atment of metastatic colorectal cancer,(CRC) and m...
...Pharmaceuticals Inc.,(TSX: TLN) announced today th...rial investigating ECO-4601 in advanced cancer,pat...e American,Society of Clinical Oncology (ASCO) Ann...ose escalation portion of the study, 14,patients (...glioma), that had completed and not responded to t...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3